Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-037021
Filing Date
2020-02-14
Accepted
2020-02-14 10:07:28
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA WANGER ASSET MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d127848dsc13g.htm SC 13G 62089
2 EX-99.I d127848dex99i.htm EX-99.I 1323
3 EX-99.II d127848dex99ii.htm EX-99.II 4649
  Complete submission text file 0001193125-20-037021.txt   70063
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

EIN.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90491 | Film No.: 20614978
SIC: 2834 Pharmaceutical Preparations